Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - In this paper, we describe 17 novel bisquaternary compounds and analyse their effect on AChE inhibition. The newly prepared compounds were evaluated in vitro using both human erythrocyte acetylcholinesterase (AChE) and human plasmatic butyrylcholinesterase. Their inhibitory ability was expressed as an IC50 and then compared to standard carbamate drugs and two AChE reactivators. One of these novel compounds provided promising AChE inhibition (nM range) in vitro and better than the currently used standards. Additionally, a kinetics assay confirmed the non-competitive inhibition of hAChE by this novel compound. Consequently, the docking results confirmed the apparent π-π or π-cationic interactions with key amino acid residues of hAChE and the binding of the chosen compound aside enzyme catalytic site.
- In this paper, we describe 17 novel bisquaternary compounds and analyse their effect on AChE inhibition. The newly prepared compounds were evaluated in vitro using both human erythrocyte acetylcholinesterase (AChE) and human plasmatic butyrylcholinesterase. Their inhibitory ability was expressed as an IC50 and then compared to standard carbamate drugs and two AChE reactivators. One of these novel compounds provided promising AChE inhibition (nM range) in vitro and better than the currently used standards. Additionally, a kinetics assay confirmed the non-competitive inhibition of hAChE by this novel compound. Consequently, the docking results confirmed the apparent π-π or π-cationic interactions with key amino acid residues of hAChE and the binding of the chosen compound aside enzyme catalytic site. (en)
|
Title
| - The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage
- The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage (en)
|
skos:prefLabel
| - The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage
- The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage (en)
|
skos:notation
| - RIV/60162694:G44__/11:00002456!RIV12-MO0-G44_____
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60162694:G44__/11:00002456
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - cholinesterase; inhibitor; pre-treatment; Myasthenia gravis; quaternary; in vitro; docking (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of Enzyme Inhibition and Medicinal Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Doležal, Martin
- Dohnal, Vlastimil
- Hrabinová, Martina
- Kuča, Kamil
- Marek, Jan
- Musílek, Kamil
- Pavlíková, Růžena
- Pohanka, Miroslav
- Gunn-Moore, Frank
- Holas, Ondřej
- Komlóová, Markéta
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |